Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAbstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity
10.1038/193151a0 · 1962
Molecular mimicry: antigen sharing by parasite and host and its consequences
10.1086/282313 · 1964
Protein interactions with small molecules. Relationships between stoichiometric binding constants, site binding constants, and empirical binding parameters
10.1016/s0021-9258(19)41586-x · 1975
Probability model for molecular recognition in biological receptor repertoires: significance to the olfactory system
10.1073/pnas.90.8.3715 · 1993
Recognition of multiple peptide cores by a single T cell receptor
10.1084/jem.182.2.531 · 1995
A very high level of crossreactivity is an essential feature of the T-cell receptor
10.1016/s0167-5699(98)01299-7 · 1998
Unresolved referenced work
1959
Unresolved referenced work
1969
Molecular mimicry and immune-mediated diseases
10.1096/fasebj.12.13.1255 · 1998
Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis
10.1084/jem.189.8.1275 · 1999
Fidelity of T Cell Activation through Multistep T Cell Receptor zeta Phosphorylation
10.1126/science.281.5376.572 · 1998
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
10.1038/80525 · 2000
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand
10.1038/80516 · 2000
Molecular mimicry and autoimmune disease
10.1016/0092-8674(87)90507-1 · 1987
Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA
10.1002/(sici)1521-4141(200004)30:4<977::aid-immu977>3.0.co;2-a · 2000
The self, the world and autoimmunity
10.1038/scientificamerican0488-52 · 1988
Discrimination and Dialogue in the Immune System
10.1006/smim.2000.0234 · 2000
Unresolved referenced work
2000
The cognitive principle challenges clonal selection
10.1016/0167-5699(92)90071-e · 1992
Autoimmunity, microbial immunity and the immunological homunculus
10.1016/0167-5699(91)90093-9 · 1991
The cognitive paradigm and the immunological homunculus
10.1016/0167-5699(92)90024-2 · 1992
Autoimmunity can benefit self-maintenance
10.1016/s0167-5699(00)01633-9 · 2000
Principles of Molecular Mimicry and Autoimmune Disease
2000
Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines
10.4049/jimmunol.128.3.1450 · 1982
Regulation of NOD mouse autoimmune diabetes by T cells that recognize a T-cell receptor CDR3 peptide
10.1093/intimm/11.6.957 · 1999
Inactivation of T cell receptor peptide specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)
10.1084/jem.184.5.1609 · 1996
Anti-Idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis
10.1126/science.2447648 · 1988
Control of Experimental Autoimmune Encephalomyelitis by T Cells Responding to Activated T Cells
10.1126/science.2471264 · 1989
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65kDa heat shock protein
10.1073/pnas.88.8.3088 · 1991
Peptide Therapy for diabetes in NOD mice
10.1016/s0140-6736(94)91582-2 · 1994
MHC-restricted depletion of human basic protein-reactive T cells by T cell vaccination
10.1126/science.7690157 · 1993
Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination
10.4049/jimmunol.164.8.4011 · 2000
Treatment of autoimmune Disease: to activate or to deactivate?
1995
No additional external references are available.
